Blinded Sugar Syrup Dose for Hypertension Trial Kit
A blinded clinical trial kit containing sugar syrup doses, formulated with over 10% sugar by dry weight, designed to simulate liquid antihypertensive medications in double-blinded studies. The syrup is put up in measured doses and packaged with active medicinals for a recognized clinical trial.
Import Duty Rates by Country of Origin
| Origin Country | MFN Tariff | Surtaxes | Total Effective Rate |
|---|---|---|---|
| 🇨🇳China | 6% | — | 6% |
| 🇲🇽Mexico | 6% | — | 6% |
| 🇺🇸United States | 6% | — | 6% |
| 🇩🇪Germany | 6% | — | 6% |
| 🇯🇵Japan | 6% | — | 6% |
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If the placebo is sugar-based (e.g., sugar powder or tablets) rather than syrup
Sugar-based placebos fall under the sibling tariff item for sugar-based clinical trial kits.
If the syrup base is not predominantly sugar or food-based
Other syrup-based placebos not meeting sugar or food criteria fall under the residual tariff item.
Not sure which classification is right?
The Tariff Assistant works through the GRI rules on your specific product to reach the right tariff item — and can price the duty on it in the same conversation.
Import Tips & Compliance
• Ensure the clinical trial is recognized by Health Canada and provide documentation (e.g
• No Objection Letter) to CBSA
• Declare the goods as pharmaceutical trial kits under tariff item 3006.93.10, and keep records of the measured doses and blinding protocol
• Verify if a Controlled Drugs and Substances Act permit is needed if the kit contains controlled substances